Cordis Pumped to Acquire Flexible Stenting Solutions
March 14, 2013
Share:
Cordis, a Johnson & Johnson company developing interventional vascular technology, has acquired Flexible Stenting Solutions, a venture-backed stent developer. Based in Eatontown, NJ, Flexible Stenting Solutions is a developer of third-generation flexible arterial and biliary stents. Exiting investors include Burrill & Company, GBP Capital and the Goodman Company. Cordis’ previous acquisitions include Ensure Medical, a developer of devices for the femoral artery, and LuMend, the creator of technology to create chronic occlusions.
